Bellevue Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,476	Closed	-$5.23M	–	144
2025 Q1	$5.23M	Sell	21,476 -12,075	-36%	-$2.94M	0.12%	87
2024 Q4	$11M	Sell	33,551 -12,600	-27%	-$4.14M	0.21%	77
2024 Q3	$15.4M	Sell	46,151 -109,107	-70%	-$36.5M	0.25%	80
2024 Q2	$42.4M	Sell	155,258 -1,360	-0.9%	-$371K	0.69%	35
2024 Q1	$54.2M	Buy	156,618 +15,471	+11%	+$5.35M	0.83%	33
2023 Q4	$45.6M	Buy	141,147 +6,817	+5%	+$2.2M	0.7%	47
2023 Q3	$48.2M	Sell	134,330 -203	-0.2%	-$72.8K	0.78%	36
2023 Q2	$51M	Buy	134,533 +20,794	+18%	+$7.88M	0.73%	44
2023 Q1	$54.5M	Buy	113,739 +2,581	+2%	+$1.24M	0.79%	45
2022 Q4	$46.7M	Buy	111,158 +9,340	+9%	+$3.93M	0.62%	53
2022 Q3	$42.5M	Buy	101,818 +10,657	+12%	+$4.45M	0.61%	48
2022 Q2	$45.1M	Buy	91,161 +19,152	+27%	+$9.48M	0.64%	50
2022 Q1	$40.6M	Buy	72,009 +32,326	+81%	+$18.2M	0.47%	67
2021 Q4	$30M	Sell	39,683 -6,332	-14%	-$4.78M	0.31%	87
2021 Q3	$34.3M	Sell	46,015 -41,286	-47%	-$30.8M	0.35%	86
2021 Q2	$56.2M	Sell	87,301 -12,901	-13%	-$8.31M	0.55%	63
2021 Q1	$57.2M	Buy	100,202 +35,797	+56%	+$20.4M	0.61%	54
2020 Q4	$37.5M	Sell	64,405 -13,781	-18%	-$8.03M	0.43%	68
2020 Q3	$40.3M	Sell	78,186 -1,685	-2%	-$869K	0.56%	52
2020 Q2	$36.1M	Buy	79,871 +17,498	+28%	+$7.9M	0.51%	49
2020 Q1	$21.9M	Buy	62,373 +15,588	+33%	+$5.46M	0.42%	62
2019 Q4	$17.3M	Buy	46,785 +40,035	+593%	+$14.8M	0.27%	67
2019 Q3	$2.25M	Buy	+6,750	New	+$2.25M	0.04%	127